top of page
Innovative Pharmaceuticals

Sensible Biotherapeutics focuses on developing innovative potential pharmaceutical products for the treatment of major diseases

COVID-19 Treatments

Sensible Biotherapeutics has filed patent aplications for future potential COVID-19 treatments, including SBT-0803 & SBT-0704

Radiopharmaceuticals

Sensible Biotherapeutics is expanding its radiopharmaceutical division to increase access to PET imaging in underserved areas

> Learn more about our COVID-19 research

An innovative future leader in antiviral

therapies & medical tech

Antisense
Therapy

Sensible Biotherapeutics is a pioneer in utilizing antisense therapy for a variety of new potential drug candidates, including a DNA oligonucleotide designed to potentially stop COVID-19 replication

Medical Device
Technology

Sensible Biotherapeutics is in development of innovative medical devices, including a generator that produces fluorine-18 for PET imaging

Clinical
Perspective

Sensible Biotherapeutics is led by Dr. Michael A. Meyer, a practicing physician with decades of experience

bottom of page